Alessia Fiore

Modena, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Abstracts of the 36th World Congress on Ultrasound in Obstetrics and Gynecology, 4-7 September 2026, London, UK.

Abstracts of the 36th World Congress on Ultrasound in Obstetrics and Gynecology, 4-7 September 2026, London, UK.

Journal: Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology
Published: July 06, 2026

Kappa Index predicts disease activity and transition to high-efficacy therapies in multiple sclerosis.

Kappa Index predicts disease activity and transition to high-efficacy therapies in multiple sclerosis.

Journal: Clinical chemistry and laboratory medicine
Published: October 12, 2025

Ofatumumab Versus Intravenous Ocrelizumab after Sphingosine-1-Phosphate Receptor Modulators in Patients with Relapsing-Remitting Multiple Sclerosis: A Real-World Inverse Probability of Treatment Weighting Multicenter Study.

Ofatumumab Versus Intravenous Ocrelizumab after Sphingosine-1-Phosphate Receptor Modulators in Patients with Relapsing-Remitting Multiple Sclerosis: A Real-World Inverse Probability of Treatment Weighting Multicenter Study.

Journal: CNS drugs
Published: September 28, 2025

Atypical clinical and MRI features in Leber hereditary optic neuropathy: a case series of four patients.

Atypical clinical and MRI features in Leber hereditary optic neuropathy: a case series of four patients.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: August 27, 2025

Impact of High-Efficacy Therapies for Multiple Sclerosis on B Cells.

Impact of High-Efficacy Therapies for Multiple Sclerosis on B Cells.

Journal: Cells
Published: February 27, 2025

Hypogammaglobulinemia and severe infections in Multiple Sclerosis patients on anti-CD20 agents: A multicentre study.

Hypogammaglobulinemia and severe infections in Multiple Sclerosis patients on anti-CD20 agents: A multicentre study.

Journal: Multiple sclerosis and related disorders
Published: June 09, 2024

Prevalence of 2-year "No evidence of disease activity" (NEDA-3 and NEDA-4) in relapsing-remitting multiple sclerosis. A real-world study.

Prevalence of 2-year "No evidence of disease activity" (NEDA-3 and NEDA-4) in relapsing-remitting multiple sclerosis. A real-world study.

Journal: Multiple sclerosis and related disorders
Published: August 10, 2023

Correspondence among gray matter atrophy and atlas-based neurotransmitter maps is clinically relevant in multiple sclerosis.

Correspondence among gray matter atrophy and atlas-based neurotransmitter maps is clinically relevant in multiple sclerosis.

Journal: Molecular psychiatry
Published: June 09, 2022

Successful treatment of paroxysmal painful tonic spasms with carbamazepine in a patient with hypertrophic olivary degeneration.

Successful treatment of paroxysmal painful tonic spasms with carbamazepine in a patient with hypertrophic olivary degeneration.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: May 09, 2022

Secondary cluster headache due to a contralateral demyelinating periaqueductal gray matter lesion.

Secondary cluster headache due to a contralateral demyelinating periaqueductal gray matter lesion.

Journal: Headache
Published: January 03, 2021

The contribution of enhancing lesions in monitoring multiple sclerosis treatment: is gadolinium always necessary?

The contribution of enhancing lesions in monitoring multiple sclerosis treatment: is gadolinium always necessary?

Journal: Journal of neurology
Published: April 10, 2020

Five- and seven-year prognostic value of new effectiveness measures (NEDA, MEDA and six-month delayed NEDA) in relapsing-remitting multiple sclerosis.

Five- and seven-year prognostic value of new effectiveness measures (NEDA, MEDA and six-month delayed NEDA) in relapsing-remitting multiple sclerosis.

Journal: Journal of the neurological sciences
Published: December 23, 2019
Showing 1-12 of 13

Last Updated: 09/26/2026